Cy
( DrugBank: - / KEGG DRUG: - )
1 disease
ID | Disease name (Link within this page) | Number of trials |
---|---|---|
60 | Aplastic anemia | 120 |
60. Aplastic anemia
Clinical trials : 245 / Drugs : 318 - (DrugBank : 86) / Drug target genes : 44 - Drug target pathways : 166
Showing 1 to 10 of 120 trials
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT05323617 (ClinicalTrials.gov) | May 15, 202320230515 | 5/4/202220220405 | Efficacy of Romiplostim in Treatment of SAA in Adults Previously Untreated With or Refractory to Immunosuppressive Therapy Efficacy of Romiplostim in Treatment of SAA in Adults Previously Untreated With or Refractory to Imm ... | Two Arm Bridging Study to Evaluate the Efficacy of Romiplostim in the Treatment of Adult Severe Aplastic Anemia Participants Who Are Either Previously Untreated With IST or Refractory to IST Two Arm Bridging Study to Evaluate the Efficacy of Romiplostim in the Treatment of Adult Severe Apla ... | Severe Aplastic Anemia (SAA) | Drug: Romiplostim;Drug: Antithymocyte Globulin;Drug: Cyclosporine A | Amgen | NULL | Not yet recruiting | 18 Years | N/A | All | 40 | Phase 2 | NULL |
2 | NCT05600426 (ClinicalTrials.gov) | January 25, 202320230125 | 20/10/202220221020 | A Trial Comparing Unrelated Donor BMT With IST for Pediatric and Young Adult Patients With Severe Aplastic Anemia (TransIT, BMT CTN 2202) A Trial Comparing Unrelated Donor BMT With IST for Pediatric and Young Adult Patients With Severe Ap ... | A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation With Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients With Severe Aplastic Anemia (TransIT, BMT CTN 2202) A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation With Immune Suppr ... | Severe Aplastic Anemia | Drug: cyclosporine;Procedure: Matched Unrelated Donor Hematopoetic Stem Cell Transplant;Drug: horse anti-thymocyte globulin (ATG);Drug: rabbit anti-thymocyte globulin (ATG);Drug: Methotrexate;Drug: Fludarabine;Drug: Cyclophosphamide;Radiation: low-dose total body irradiation (TBI);Procedure: Immunosuppressive Therapy (IST) Drug: cyclosporine;Procedure: Matched Unrelated Donor Hematopoetic Stem Cell Transplant;Drug: horse ... | Boston Children's Hospital | Center for International Blood and Marrow Transplant Research;National Institutes of Health (NIH);National Heart, Lung, and Blood Institute (NHLBI);North American Pediatric Aplastic Anemia Consortium;Pediatric Transplantation and Cellular Therapy Consortium;Blood and Marrow Transplant Clinical Trials Network Center for International Blood and Marrow Transplant Research;National Institutes of Health (NIH);Na ... | Recruiting | 0 Years | 25 Years | All | 234 | Phase 3 | United States |
3 | ChiCTR2200056659 | 2023-01-1620230116 | 2022-02-1020220210 | Allopurinol in the treatment of cyclosporine-induced hyperuricemia in children with aplastic anemia:a randomized controlled study Allopurinol in the treatment of cyclosporine-induced hyperuricemia in children with aplastic anemia: ... | Allopurinol in the treatment of cyclosporine-induced hyperuricemia in children with aplastic anemia:a randomized controlled study Allopurinol in the treatment of cyclosporine-induced hyperuricemia in children with aplastic anemia: ... | hyperuricemia | Allopurinol group:Receive allopurinol tablets;Placebo group:Receive placebo; | The Seventh Affiliated Hospital, Sun Yat-sen University | NULL | Pending | 1 | 18 | Both | Allopurinol group:20;Placebo group:20; | Phase 4 | China |
4 | NCT05660785 (ClinicalTrials.gov) | December 1, 202220221201 | 23/11/202220221123 | Herombopag Added to Cyclosporine in Non Severe Aplastic Anemia | The Efficacy and Safety of Herombopag Combined With Cyclosporine for Patients With Non Severe Aplastic Anemia The Efficacy and Safety of Herombopag Combined With Cyclosporine for Patients With Non Severe Aplast ... | Non Severe Aplastic Anemia;Untreated | Drug: Herombopag | Institute of Hematology & Blood Diseases Hospital | Jiangsu Hengrui Pharmaceuticals Co.,Ltd | Recruiting | 18 Years | N/A | All | 54 | Phase 2 | China |
5 | NCT05031897 (ClinicalTrials.gov) | October 25, 202120211025 | 31/8/202120210831 | Reduced-Intensity Conditioning for the Prevention of Treatment-Related Mortality in Patients Who Undergo a Hematopoietic Stem Cell Transplant Reduced-Intensity Conditioning for the Prevention of Treatment-Related Mortality in Patients Who Und ... | A 2 Step Approach to Haploidentical Transplant Using Radiation-Based Reduced Intensity Conditioning | Acute Lymphoblastic Leukemia;Acute Myeloid Leukemia;Aplastic Anemia;Chronic Lymphocytic Leukemia;Chronic Myelomonocytic Leukemia;Essential Thrombocythemia;Hematopoietic and Lymphoid Cell Neoplasm;Hodgkin Lymphoma;Myelodysplastic Syndromes;Myelofibrosis;Myeloid Leukemia;Myeloid Neoplasm;Non-Hodgkin Lymphoma;Plasma Cell Myeloma;Polycythemia Vera;Small Lymphocytic Lymphoma Acute Lymphoblastic Leukemia;Acute Myeloid Leukemia;Aplastic Anemia;Chronic Lymphocytic Leukemia;Chr ... | Procedure: Hematopoietic Cell Transplantation;Drug: Mycophenolate Mofetil;Drug: Tacrolimus;Drug: Cyclophosphamide;Radiation: Total-Body Irradiation;Procedure: Donor Lymphocyte Infusion;Drug: Fludarabine;Drug: Melphalan Procedure: Hematopoietic Cell Transplantation;Drug: Mycophenolate Mofetil;Drug: Tacrolimus;Drug: Cyc ... | Thomas Jefferson University | NULL | Recruiting | 18 Years | N/A | All | 67 | Phase 2 | United States |
6 | NCT05049668 (ClinicalTrials.gov) | October 202120211000 | 13/9/202120210913 | RACE 2: a Long Term Follow-up of Patients Participating in the RACE Trial | Long-term Follow-up of Patients Participating in RACE: the Prospective Randomized Multicenter Study Comparing Horse Antithymocyte Globuline (hATG) + Cyclosporine A (CsA) With or Without Eltrombopag as Front-line Therapy for Severe Aplastic Anemia Patients Long-term Follow-up of Patients Participating in RACE: the Prospective Randomized Multicenter Study ... | Severe Aplastic Anemia | Drug: ATGAM plus CsA with or without Eltrombopag | European Society for Blood and Marrow Transplantation | NULL | Enrolling by invitation | N/A | N/A | All | 197 | France | |
7 | ChiCTR2100050948 | 2021-09-1020210910 | 2021-09-0820210908 | Comparison of clinical efficacy and safety of hematopoietic stem cell transplantation and immunosuppression in the treatment of hepatitis-related aplastic anemia: a single-center cohort study Comparison of clinical efficacy and safety of hematopoietic stem cell transplantation and immunosupp ... | Comparison of clinical efficacy and safety of hematopoietic stem cell transplantation and immunosuppressive therapy in patients with hepatitis-related aplastic anemia Comparison of clinical efficacy and safety of hematopoietic stem cell transplantation and immunosupp ... | Hepatitis-associated Aplastic Anemia | ematopoietic stem cell transplantation group:Nil;ATG combined with cyclosporine group :Nil; | Zhejiang Provincial Hospital of Traditional Chinese Medicine | NULL | Recruiting | 1 | 50 | Both | ematopoietic stem cell transplantation group:30;ATG combined with cyclosporine group :30; | China | |
8 | ChiCTR2100047288 | 2021-06-0120210601 | 2021-06-1120210611 | Efficacy and safety of combined immunosuppressive therapy plus umbilical cord blood infusion in myelodysplastic syndromes/aplastic anemia patients: a clinical observation study Efficacy and safety of combined immunosuppressive therapy plus umbilical cord blood infusion in myel ... | Efficacy and safety of combined immunosuppressive therapy plus umbilical cord blood infusion in myelodysplastic syndromes/aplastic anemia patients: a clinical observation study Efficacy and safety of combined immunosuppressive therapy plus umbilical cord blood infusion in myel ... | myelodysplastic syndromes/aplastic anemi | Experimental group1:According to the classification, ATG + CsA/CSA alone is used as the pretreatment plan/supportive treatment + non-blood cord blood stem cell infusion treatment;Experimental group2:Decitabine+cytarabine/decitabine alone is used as the pretreatment plan/supportive treatment+non-blood cord blood stem cell infusion treatment according to the classification; Experimental group1:According to the classification, ATG + CsA/CSA alone is used as the pretreatment ... | The Second Affiliated Hospital of Xi'an Jiaotong University (Xibei Hospital) | NULL | Recruiting | 18 | 90 | Both | Experimental group1:10;Experimental group2:10; | China | |
9 | ChiCTR2100043229 | 2021-02-2220210222 | 2021-02-0920210209 | A Single-Center, Single-Arm, Phase II Clinical Study of the Efficacy and Safety of Cyclosporine Combined with Eltrombopag Olamine Tablets in Treatment-Naive Transfusion-Dependent Non-Severe Aplastic Anemia A Single-Center, Single-Arm, Phase II Clinical Study of the Efficacy and Safety of Cyclosporine Comb ... | A Single-Center, Single-Arm, Phase II Clinical Study of the Efficacy and Safety of Cyclosporine Combined with Eltrombopag Olamine Tablets in Treatment-Naive Transfusion-Dependent Non-Severe Aplastic Anemia A Single-Center, Single-Arm, Phase II Clinical Study of the Efficacy and Safety of Cyclosporine Comb ... | Aplastic anemia | Durgs Group:Elrombopag combined with Cyclosporine; | Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences | NULL | Recruiting | 18 | 85 | Both | Durgs Group:61; | Phase 2 | China |
10 | ChiCTR2000041485 | 2021-01-0120210101 | 2020-12-2720201227 | Efficacy of Danazol after no response to cyclosporin in transfusion independent aplastic anemia: a prospective study Efficacy of Danazol after no response to cyclosporin in transfusion independent aplastic anemia: a p ... | Efficacy of Danazol after no response to cyclosporin in transfusion independent aplastic anemia: a prospective study Efficacy of Danazol after no response to cyclosporin in transfusion independent aplastic anemia: a p ... | transfusion independent aplastic anemia | experimental group:Cyclosporine combined with danazol;control group:Cyclosporine; | Institute of Hematology & Hospital of Blood Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College Institute of Hematology & Hospital of Blood Diseases, Chinese Academy of Medical Sciences & Peking U ... | NULL | Recruiting | Both | experimental group:152;control group:76; | Phase 4 | China |